欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

您的位置: 首页 / 单抗抑制剂 / Bevacizumab

CAS No.: 216974-75-3

Bevacizumab

Bevacizumab is a recombinant humanized monoclonal immunoglobulin (Ig) G1 antibody that binds to all isoforms and bioactive proteolytic fragments of human vascular endothelial growth factor-A (VEGF), which is essential for both normal and tumor angiogenesis.

规格 价格 库存
1 mg RMB 1488 in stock

描述

Bevacizumab is a recombinant humanized monoclonal immunoglobulin (Ig) G1 antibody that binds to all isoforms and bioactive proteolytic fragments of human vascular endothelial growth factor-A (VEGF), which is essential for both normal and tumor angiogenesis. It is approved for the treatment of patients with metastatic colorectal cancer, advanced nonsquamous non-small cell lung cancer, metastatic renal cell carcinoma, recurrent glioblastoma, advanced cervical cancer, and platinum-resistant ovarian cancer.

同义词

Avastin

参考

Li M, Kroetz DL. Bevacizumab-induced hypertension: Clinical presentation and molecular understanding. Pharmacol Ther. 2018;182:152-160. doi:10.1016/j.pharmthera.2017.08.012|https://pubmed.ncbi.nlm.nih.gov/28882537/

大规格询价

号为必填项

姓名: 邮箱: 手机号:
留言:
   提交
联系
我们